/NOT FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES OR DISSEMINATION IN
THE UNITED STATES/
CALGARY, July 26, 2013 /CNW/ - Vivione Biosciences Inc. ("Vivione") (TSXV: VBI) is pleased to announce that it has signed a collaboration
agreement with the University of Arkansas Department of Food Science
and the University of Arkansas System Division of Agriculture Center
for Food Safety.
This collaboration is for a 12 month period with annual renewals during
which Vivione and the university will work together on mutually agreed
to projects. These projects will include literature searches and
objective studies of RAPID-B's performance relative to other methods.
These projects will include existing as well as future assays.
Vivione is commercializing its RAPID-B diagnostic platform into the food
safety market. RAPID-B has the potential to provide food pathogen
detection down to a single cell in as little as seven hours (including
sample preparation) versus the days that it takes with competitive
systems. The rapid time to results capability could allow food
processors to more closely monitor their manufacturing plants, incoming
raw materials as well as mitigate the risk of a food safety recall.
"The University of Arkansas is one the leading agricultural universities
in the United States," said Kevin Kuykendall, Vivione's CEO. "In
addition to being on the leading edge of the technologies and research
that are driving ongoing improvements in food science, they also have a
unique perspective due to their strong relationships with some of the
largest global food companies. We are very happy to be working with
them to help refine our products as well as having the university being
an objective judge of our analytical performance."
Steven C. Ricke, Director of the Center for Food Safety, said, "We have
been informally involved with Vivione's RAPID-B platform for a number
of years and have appreciated all of the work that has gone into the
platform's development. We are very pleased to now formalize our
relationship and are looking forward to actively contributing to
RAPID-B's success. Vivione's RAPID-B platform could have a dramatic
impact on a customer's food safety program. The ability to sample,
analyze, and intervene all within a manufacturing shift is a
significant improvement over existing pathogen detection technologies.
RAPID-B's ability to detect a single cell of bacteria in seven hours or
less, including sample preparation time will provide food producers
with the ability to reduce inventory hold times and improve
manufacturing efficiencies, and ultimately reduce their product
Vivione partnered with the federal Food and Drug Administration National
Center for Toxicological Research in Jefferson, Ark., for more than six
years to develop RAPID-B. Vivione believes RAPID-B has the potential to
provide for the rapid detection of bacterial pathogens, making RAPID-B
applicable to the food safety, clinical diagnostics and other markets
including agricultural, water testing, pharmaceutical and medical
The Department of Food Science consists of 14 nationally recognized
faculty and 10 adjunct faculty with support personnel who are dedicated
to teaching, research and service in areas of food chemistry and
quality, microbial food safety, food processing, food packaging,
sensory analysis, food engineering, functionality and health benefits
of foods. The department's facilities including classrooms,
laboratories and food processing pilot plant are modern and well
equipped for effective education and research.
The mission of the Center for Food Safety is to conduct research on the
safety and quality of food products with a focus on biological,
chemical and physical hazards. The center is dedicated to the
development and utilization of advanced research technologies and to
the communication of research findings to assist in building public
confidence in the protection, safety, quality and nutritional value of
This news release contains "forward-looking statements" within the
meaning of applicable securities laws. Although Vivione believes that
the expectations reflected in its forward-looking statements are
reasonable, such statements have been based on factors and assumptions
concerning future events that may prove to be inaccurate. These factors
and assumptions are based upon currently available information to
Vivione. Such statements are subject to known and unknown risks,
uncertainties and other factors that could influence actual results or
events and cause actual results or events to differ materially from
those stated, anticipated or implied in the forward-looking statements.
In particular, this press release contains forward-looking information
relating to the commercialization and anticipated effectiveness of
RAPID-B. Readers are cautioned to not place undue reliance on
forward-looking statements. The statements in this press release are
made as of the date of this release and, except as required by
applicable law, Vivione does not undertake any obligation to publicly
update or to revise any of the included forward-looking statements,
whether as a result of new information, future events or otherwise.
Vivione undertakes no obligation to comment on analyses, expectations
or statements made by third-parties in respect of Vivione, or its
financial or operating results or (as applicable), their securities.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICE PROVIDER (AS
THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE)
ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
SOURCE: Vivione Biosciences Inc.
For further information:
Vivione Biosciences Inc.
Chief Executive Officer
Tel: (214) 886-5733
University of Arkansas
Steven C. Ricke, Center for Food Safety
Tel: (479) 575-4678